Robotic stereotactic boost in early breast cancer, a phase II trial

This phase II trial of single-dose stereotactic boost after conventional breast irradiation in early breast cancer showed excellent local control, toxicity profile and quality of life on general and breast specific items with median follow up of 38 months.

https://ift.tt/2JigOyD